PubMed

Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy.

Westerweel PE, Visseren FL, Hajer GR, Olijhoek JK, Hoefer IE, de Bree P, Rafii S, Doevendans PA, Verhaar MC.

Eur Heart J. 2008 Nov;29(22):2808-17. Epub 2008 Sep 28.PMID: 18824462 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.

Olijhoek JK, Hajer GR, van der Graaf Y, Dallinga-Thie GM, Visseren FL.

J Cardiovasc Pharmacol. 2008 Aug;52(2):145-50.PMID: 18670365 [PubMed - indexed for MEDLINE]Related articles

Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.

Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Olijhoek JK, Visseren FL.

Clin Endocrinol (Oxf). 2008 Dec;69(6):870-7. Epub 2008 Apr 3.PMID: 18394022 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.

Wassink AM, van der Graaf Y, Olijhoek JK, Visseren FL; SMART Study Group.

Eur Heart J. 2008 Jan;29(2):213-23.PMID: 18199567 [PubMed - indexed for MEDLINE]Related articlesFree article

Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease.

Hajer GR, van der Graaf Y, Olijhoek JK, Edlinger M, Visseren FL.

Am Heart J. 2007 Oct;154(4):750.e1-7.PMID: 17893004 [PubMed - indexed for MEDLINE]Related articles

Defining the metabolic syndrome: Resolving unresolved issues?

Olijhoek JK, van der Graaf Y, Haffner SM, Visseren FL; for the SMART Study Group.

Eur J Intern Med. 2007 Jul;18(4):309-13.PMID: 17574106 [PubMed - in process]Related articles

Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease.

Martens FM, van der Graaf Y, Dijk JM, Olijhoek JK, Visseren FL.

Atherosclerosis. 2008 Apr;197(2):646-53. Epub 2007 Mar 19.PMID: 17374372 [PubMed - indexed for MEDLINE]Related articles

The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease.

Goessens BM, van der Graaf Y, Olijhoek JK, Visseren FL; SMART Study Group.

J Vasc Surg. 2007 Jan;45(1):47-54.PMID: 17210381 [PubMed - indexed for MEDLINE]Related articles

The metabolic syndrome: metabolic changes with vascular consequences.

Wassink AM, Olijhoek JK, Visseren FL.

Eur J Clin Invest. 2007 Jan;37(1):8-17.PMID: 17181562 [PubMed - indexed for MEDLINE]Related articles

Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome.

Hajer GR, van der Graaf Y, Olijhoek JK, Verhaar MC, Visseren FL; SMART Study Group.

Heart. 2007 Feb;93(2):216-20. Epub 2006 Sep 4.PMID: 16952974 [PubMed - indexed for MEDLINE]Related articles

Multidisciplinary vascular screening program modestly improves the medical treatment of vascular risk factors.

Goessens BM, Visseren FL, Olijhoek JK, Eikelboom BC, van der Graaf Y.

Cardiovasc Drugs Ther. 2005 Dec;19(6):429-35.PMID: 16453088 [PubMed - indexed for MEDLINE]Related articles

[The metabolic syndrome: a cluster of vascular risk factors]

Olijhoek JK, Martens FM, Banga JD, Visseren FL.

Ned Tijdschr Geneeskd. 2005 Apr 16;149(16):859-65. Review. Dutch. PMID: 15868989 [PubMed - indexed for MEDLINE]Related articles

Presence of the metabolic syndrome does not impair coronary collateral vessel formation in patients with documented coronary artery disease.

Olijhoek JK, Koerselman J, de Jaegere PP, Verhaar MC, Grobbee DE, van der Graaf Y, Visseren FL; SMART Study Group.

Diabetes Care. 2005 Mar;28(3):683-9.PMID: 15735208 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral glucose tolerance test or metabolic syndrome criteria to predict risk in patients with coronary heart disease?

Olijhoek JK, Banga JD, Doevendans PA, Visseren FL.

Eur Heart J. 2005 Mar;26(6):623; author reply 623-4. Epub 2005 Feb 15. No abstract available. PMID: 15713696 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.

Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ, Visseren FL; SMART Study Group.

Atherosclerosis. 2004 Apr;173(2):363-9.PMID: 15064114 [PubMed - indexed for MEDLINE]Related articles

The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm.

Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL; SMART Study Group.

Eur Heart J. 2004 Feb;25(4):342-8.PMID: 14984924 [PubMed - indexed for MEDLINE]Related articlesFree article